Trial intelligence / Profile preview

Ramosetron PK/PD in CINV

NCT02076529Completed

Sponsor
Chonnam National University Hospital
Start
Oct 2012
Primary completion
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of ramosetron in chemotherapy-induced nausea and vomiting (CINV) (3 arms), sponsored by Chonnam National University Hospital. Primary endpoint: Pharmacokinetic profile of Ramosetron. Started Oct 2012; status: completed.

02

Drugs

ramosetron
03

Conditions

chemotherapy-induced nausea and vomiting (CINV)

Beyond the preview

Go deeper on NCT02076529.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02076529.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call